Circumvention of Mcl-1-Dependent Drug Resistance by Simultaneous Chk1 and MEK1/2 Inhibition in Human Multiple Myeloma Cells
出版年份 2014 全文链接
标题
Circumvention of Mcl-1-Dependent Drug Resistance by Simultaneous Chk1 and MEK1/2 Inhibition in Human Multiple Myeloma Cells
作者
关键词
-
出版物
PLoS One
Volume 9, Issue 3, Pages e89064
出版商
Public Library of Science (PLoS)
发表日期
2014-03-05
DOI
10.1371/journal.pone.0089064
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Management of Relapsed and Relapsed/Refractory Multiple Myeloma
- (2017) Jacob P. Laubach et al. Journal of the National Comprehensive Cancer Network
- Purported Mcl-1 inhibitor marinopyrrole A fails to show selective cytotoxicity for Mcl-1-dependent cell lines
- (2013) J M Eichhorn et al. Cell Death & Disease
- Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma
- (2012) D. J. Kuhn et al. BLOOD
- CDK Inhibitors Upregulate BH3-Only Proteins to Sensitize Human Myeloma Cells to BH3 Mimetic Therapies
- (2012) Shuang Chen et al. CANCER RESEARCH
- Mcl-1 Phosphorylation Defines ABT-737 Resistance That Can Be Overcome by Increased NOXA Expression in Leukemic B cells
- (2012) S. Mazumder et al. CANCER RESEARCH
- Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors
- (2012) G. J. Gores et al. GENES & DEVELOPMENT
- Up-regulation of Pro-apoptotic Protein Bim and Down-regulation of Anti-apoptotic Protein Mcl-1 Cooperatively Mediate Enhanced Tumor Cell Death Induced by the Combination of ERK Kinase (MEK) Inhibitor and Microtubule Inhibitor
- (2012) Takumi Kawabata et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bone Marrow Microenvironment in Multiple Myeloma Progression
- (2012) S. Manier et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Molecular Mechanisms of Acquired Proteasome Inhibitor Resistance
- (2012) Andrew J. Kale et al. JOURNAL OF MEDICINAL CHEMISTRY
- Latest advances and current challenges in the treatment of multiple myeloma
- (2012) Anuj Mahindra et al. Nature Reviews Clinical Oncology
- Thr 163 Phosphorylation Causes Mcl-1 Stabilization when Degradation Is Independent of the Adjacent GSK3-Targeted Phosphodegron, Promoting Drug Resistance in Cancer
- (2012) Shanna K. Nifoussi et al. PLoS One
- Shifting the balance of mitochondrial apoptosis: therapeutic perspectives
- (2012) Simone Fulda Frontiers in Oncology
- Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition
- (2011) J. Hu et al. BLOOD
- Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2
- (2011) X.-Y. Pei et al. BLOOD
- Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL/Bcl-2 in Mcl-1-expressing myeloma cells
- (2011) A. A. Morales et al. BLOOD
- Disruption of IκB Kinase (IKK)-mediated RelA Serine 536 Phosphorylation Sensitizes Human Multiple Myeloma Cells to Histone Deacetylase (HDAC) Inhibitors
- (2011) Yun Dai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex
- (2011) M Konopleva et al. LEUKEMIA
- Disruption of Src function potentiates Chk1-inhibitor-induced apoptosis in human multiple myeloma cells in vitro and in vivo
- (2010) Y. Dai et al. BLOOD
- Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo
- (2010) Kihyun Kim et al. BRITISH JOURNAL OF HAEMATOLOGY
- Nucleoside analog ARC targets Mcl-1 to induce apoptosis in leukemia cells
- (2010) U G Bhat et al. LEUKEMIA
- ARC Synergizes with ABT-737 to Induce Apoptosis in Human Cancer Cells
- (2010) U. G. Bhat et al. MOLECULAR CANCER THERAPEUTICS
- Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
- (2010) Douglas W McMillin et al. NATURE MEDICINE
- FoxM1 Is a General Target for Proteasome Inhibitors
- (2009) Uppoor G. Bhat et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started